As OMA1 is pro-apoptotic through OPA1 processing, the inhibition of OMA1 promotes glycolytic metabolism and tumor progression in colorectal cancer [100], while activating OMA1 increases chemotherapeutic effectiveness in ovarian cancer settings [101]. This evidence concerns the gene OMA1 and ovarian carcinoma.